Saturday, November 28, 2020

Carlyle After Another Indian Pharma Company


Seeking Alpha reported:

  • Carlyle Group is in advanced talks to buy Granules India, a pharmaceuticals maker, for ~$1B, India's CNBC-TV18 reports, citing three sources with direct knowledge of the deal.
  • That would add on to Carlyle's pharmaceutical industry investments after recently acquiring Sequent Scientific and a  minority stake in Piramal Pharma.

It's not clear how Granules might grow Carlyle's COVID-19 profit plans.  Granules does have a clinical research and manufacturing arm as well as a number of FDA approved drug production sites.

Where Americans see high costs, Carlyle sees grand profits.